FactorPad
Build a Better Process

Stock Risk Measures for Kura Oncology Inc

A quantitative factor review, as of October 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: November 02, 2020
See how we arrive at an overall risk score of 54 for KURA below.

/ factorpad.com / stocks / f49zrw.html


An ad-free and cookie-free webpage by FactorPad


KURA Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Kura Oncology Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how KURA stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f49zrw.html


KURA stock risk
KURA ONCOLOGY INC stock beta
KURA risk report
KURA f49zrw
KURA risk analysis
KURA volatility
KURA ONCOLOGY INC credit risk
KURA liquidity risk
KURA leverage
KURA valuation
KURA systematic risk
KURA specific risk
KURA ONCOLOGY INC volatility
KURA analysis
KURA financial ratio

This is a new resource, spread the word, tell a friend